Ubs Asset Management Americas Inc Novo Cure LTD Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,371,531 shares of NVCR stock, worth $17.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,371,531
Previous 1,782,159
23.04%
Holding current value
$17.4 Million
Previous $31.8 Million
23.13%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding NVCR
# of Institutions
284Shares Held
77.5MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$154 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$137 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.9MShares$87.8 Million9.53% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$81.2 Million0.02% of portfolio
-
State Street Corp Boston, MA2.68MShares$34.1 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.33B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...